| For: | Prince M, Lester L, Chiniwala R, Berger B. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients. World J Gastroenterol 2017; 23(3): 464-471 [PMID: 28210082 DOI: 10.3748/wjg.v23.i3.464] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i3/464.htm |
| Number | Citing Articles |
| 1 |
Quang A. Le, Mallik Greene, Shrey Gohil, A. Burak Ozbay, Michael Dore, A. Mark Fendrick, Paul Limburg. Adherence to multi-target stool DNA testing for colorectal cancer screening in the United States. International Journal of Colorectal Disease 2025; 40(1) doi: 10.1007/s00384-025-04805-0
|
| 2 |
Linda Jiang, Keming Yang, Melissa Saul, Ravy K. Vajravelu, Robert E. Schoen. Multitarget Stool DNA Testing for Colorectal Cancer Screening in Clinical Practice. American Journal of Gastroenterology 2025; 120(10) doi: 10.14309/ajg.0000000000003276
|
| 3 |
Jessica M. Gowing, Beth-Ann Shanker, Tendai K. Thomas, Robert K. Cleary. Primary Care Physicians and Patients Prefer Colonoscopy for Colorectal Cancer Screening. Diseases of the Colon & Rectum 2023; 66(3) doi: 10.1097/DCR.0000000000002618
|
| 4 |
Divya B. Bhatt, Valerie-Sue Emuakhagbon. Current Trends in Colorectal Cancer Screening. Current Colorectal Cancer Reports 2019; 15(2) doi: 10.1007/s11888-019-00432-4
|
| 5 |
E. Hacker, B. Baker, T. Lake, C. Ross, M. Cox, C. Davies, S.R. Skinner, R. Booy, A. Forster. Vaccine microarray patch self-administration: An innovative approach to improve pandemic and routine vaccination rates. Vaccine 2023; 41(41) doi: 10.1016/j.vaccine.2023.08.027
|
| 6 |
Thomas K. Kleinschmidt, Austin Clements, Mark A. Parker, Steven D. Scarcliff. Retrospective Review of Multitarget Stool DNA as a Screening Test for Colorectal Cancer. The American Surgeon™ 2023; 89(4) doi: 10.1177/00031348211031844
|
| 7 |
Nimish Vakil, Kristin Ciezki, Nadia Huq, Maharaj Singh. Multitarget stool DNA testing for the prevention of colon cancer: outcomes in a large integrated healthcare system. Gastrointestinal Endoscopy 2020; 92(2) doi: 10.1016/j.gie.2019.12.027
|
| 8 |
Emily Weiser, Philip D Parks, Rebecca K Swartz, Jack Van Thomme, Philip T Lavin, Paul Limburg, Barry M Berger. Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening: Real-world data from a large cohort of older adults. Journal of Medical Screening 2021; 28(1) doi: 10.1177/0969141320903756
|
| 9 |
Lesley-Ann Miller-Wilson, Lila J Finney Rutten, Jack Van Thomme, A Burak Ozbay, Paul J Limburg. Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a large, nationally insured cohort. International Journal of Colorectal Disease 2021; 36(11) doi: 10.1007/s00384-021-03956-0
|
| 10 |
Mohammad Amin Kerachian, Ali Javadmanesh, Marjan Azghandi, Afsaneh Mojtabanezhad Shariatpanahi, Maryam Yassi, Ehsan Shams Davodly, Amin Talebi, Fatemeh Khadangi, Ghodratollah Soltani, Abdorasool Hayatbakhsh, Kamran Ghaffarzadegan. Crosstalk between DNA methylation and gene expression in colorectal cancer, a potential plasma biomarker for tracing this tumor. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59690-0
|
| 11 |
John B. Kisiel, Jason D. Eckmann, Paul J. Limburg. Multitarget Stool DNA for Average Risk Colorectal Cancer Screening. Gastrointestinal Endoscopy Clinics of North America 2020; 30(3) doi: 10.1016/j.giec.2020.02.008
|
| 12 |
Daniele Santini, Andrea Botticelli, Antonio Galvano, Michele Iuliani, Lorena Incorvaia, Valerio Gristina, Chiara Taffon, Simone Foderaro, Elisa Paccagnella, Sonia Simonetti, Federico Fazio, Simone Scagnoli, Giulia Pomati, Francesco Pantano, Giuseppe Perrone, Elena De Falco, Antonio Russo, Gian Paolo Spinelli. Network approach in liquidomics landscape. Journal of Experimental & Clinical Cancer Research 2023; 42(1) doi: 10.1186/s13046-023-02743-9
|
| 13 |
Joshua J Ofman, William Dahut, Ahmedin Jemal, Ellen T Chang, Christina A Clarke, Earl Hubbell, Anuraag R Kansal, Allison W Kurian, Graham A Colditz, Alpa V Patel. Estimated proportion of cancer deaths not addressed by current cancer screening efforts in the United States. Cancer Biomarkers 2025; 42(1) doi: 10.1177/18758592241308754
|
| 14 |
Mallik Greene, Shrey Gohil, Mark Camardo, A. Burak Ozbay, Paul Limburg, Jerry Lovelace. Adherence to mt-sDNA testing for colorectal cancer screening among new users in a US Black population. Current Medical Research and Opinion 2025; 41(3) doi: 10.1080/03007995.2025.2475074
|
| 15 |
Kaden R. Narayani, Raj I. Narayani. Influence of Colorectal Cancer Risk Factors on Predictive Value of a Positive Multitarget Stool DNA Test. Journal of Clinical Gastroenterology 2024; 58(5) doi: 10.1097/MCG.0000000000001884
|
| 16 |
T. Sharma. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults. Public Health 2020; 182 doi: 10.1016/j.puhe.2020.01.021
|
| 17 |
Linda Morrow, Beverly Greenwald. Improving the rate of colorectal cancer screening with the “80% in every community” campaign. Journal of the American Association of Nurse Practitioners 2021; 33(11) doi: 10.1097/JXX.0000000000000465
|
| 18 |
Ann Tivey, Matt Church, Dominic Rothwell, Caroline Dive, Natalie Cook. Circulating tumour DNA — looking beyond the blood. Nature Reviews Clinical Oncology 2022; 19(9) doi: 10.1038/s41571-022-00660-y
|
| 19 |
Perry J. Pickhardt, Loredana Correale, Cesare Hassan. PPV and Detection Rate of mt-sDNA Testing, FIT, and CT Colonography for Advanced Neoplasia: A Hierarchic Bayesian Meta-Analysis of the Noninvasive Colorectal Screening Tests. American Journal of Roentgenology 2021; 217(4) doi: 10.2214/AJR.20.25416
|
| 20 |
Olubunmi Oladunjoye, Isabel Valdez. Improving Colorectal Screening Compliance Through Targeted Quality Improvement Interventions in Primary Care. Cureus 2025; doi: 10.7759/cureus.96031
|
| 21 |
Mallik Greene, Shrey Gohil, Juliana Vanessa Rincón López, Jerry Lovelace, A Mark Fendrick, Martha Duarte, Michael Dore, Joseph C. Anderson, Jordan K. Karlitz, Quang A. Le. High Adherence to Repeat Multitarget Stool DNA Testing and Follow-Up Colonoscopy in Average-Risk United States Adults: Results from a Nationally Insured Cohort. Clinical Therapeutics 2026; 48(8) doi: 10.1016/j.clinthera.2025.10.015
|
| 22 |
Erica K. Barnell, Yiming Kang, Andrew R. Barnell, Kimberly R. Kruse, Jared Fiske, Zachary R. Pittz, Adnan R. Khan, Thomas A. Huebner, Faith L. Holmes, Malachi Griffith, Obi L. Griffith, Aadel A. Chaudhuri, Elizabeth M. Wurtzler. Multitarget Stool RNA Test for Noninvasive Detection of Colorectal Neoplasia in a Multicenter, Prospective, and Retrospective Cohort. Clinical and Translational Gastroenterology 2021; 12(5) doi: 10.14309/ctg.0000000000000360
|
| 23 |
Diana Redwood, Christie Flanagan, Lauren Jeffries, Peter Holck, Lila Finney Rutten, Christine Desnoyers, Danika Bailie, John Kisiel. Increasing colorectal cancer screening among Alaska Native peoples living in remote areas of Alaska: a multitarget stool DNA cluster randomized controlled trial. BMC Primary Care 2026; 27(1) doi: 10.1186/s12875-026-03370-x
|
| 24 |
Melanie Tepus, Tung On Yau. Non-Invasive Colorectal Cancer Screening: An Overview. Gastrointestinal Tumors 2020; 7(3) doi: 10.1159/000507701
|
| 25 |
Jie He, Shen-Bin Pan, Ai-Ru Yu, Ke Xu. Diagnostic value of methylated branched chain amino acid transaminase 1/IKAROS family zinc finger 1 for colorectal cancer. World Journal of Gastroenterology 2023; 29(36): 5240-5253 doi: 10.3748/wjg.v29.i36.5240
Abstract(996) |
Core Tip(995) |
Full Article(HTML)(2751)
|
Full Article (PDF)-4190K(246)
|
Full Article with Cover (PDF)-4397K(232)
|
Full Article (Word)-892K(46)
|
Full Article (XML)-157K(171)
|
Audio-281K(16)
|
Peer-Review Report-247K(174)
|
Answering Reviewers-181K(168)
|
Supplementary Material-49K(182)
|
Times Cited (4)
|
Total Visits (4746)
|
Open
|
| 26 |
Diana G. Redwood, Ian D. Blake, Ellen M. Provost, John B. Kisiel, Frank D. Sacco, David A. Ahlquist. Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening. Journal of Primary Care & Community Health 2019; 10 doi: 10.1177/2150132719884295
|
| 27 |
Aneta L. Zygulska, Piotr Pierzchalski. Novel Diagnostic Biomarkers in Colorectal Cancer. International Journal of Molecular Sciences 2022; 23(2) doi: 10.3390/ijms23020852
|
| 28 |
Nikit Venishetty, Jessica Calderon-Mora, Navkiran K. Shokar, Pracheta Matharasi, Luis Garza, Celina Beltran, Jennifer Molokwu. Implementing a mailed stool sample screening program in clinics providing care for an underserved Hispanic population. Cancer Treatment and Research Communications 2023; 37 doi: 10.1016/j.ctarc.2023.100756
|
| 29 |
Jason D. Eckmann, Derek W. Ebner, John B. Kisiel. Multi-Target Stool DNA Testing for Colorectal Cancer Screening: Emerging Learning on Real-world Performance. Current Treatment Options in Gastroenterology 2020; 18(1) doi: 10.1007/s11938-020-00271-5
|
| 30 |
Mallik Greene, Timo Pew, Shrey Gohil, A. Burak Ozbay, Juliana Vanessa Rincón López, Paul Limburg, Martha Duarte. Association Between Spanish-Language Patient Navigation and Adherence to Multi-Target Stool DNA Testing Among Spanish-Speaking Patients at Sanitas Medical Center. Journal of Cancer Education 2025; doi: 10.1007/s13187-025-02742-8
|
| 31 |
Seyed Mohammad Amin Kormi, Shima Ardehkhani, Mohammad Amin Kerachian. New insights into colorectal cancer screening and early detection tests. Colorectal Cancer 2017; 6(2) doi: 10.2217/crc-2017-0007
|
| 32 |
Lauren A. Jeffries, Christie A. Flanagan, Lila J. Finney Rutten, John B. Kisiel, Diana G. Redwood. Factors Influencing the Choice Between Multi-Target Stool DNA and Colonoscopy for Colorectal Cancer Screening Among Alaska Native Peoples. Life 2025; 15(1) doi: 10.3390/life15010120
|
| 33 |
Deborah A. Fisher, Jordan J. Karlitz, Sushanth Jeyakumar, Nathaniel Smith, Paul Limburg, David Lieberman, A. Mark Fendrick. Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population. Journal of Medical Economics 2021; 24(1) doi: 10.1080/13696998.2021.1922240
|
| 34 |
William M. Grady, Ming Yu, Sanford D. Markowitz. Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer. Gastroenterology 2021; 160(3) doi: 10.1053/j.gastro.2020.09.058
|
| 35 |
John B. Kisiel, Paul J. Limburg. Colorectal Cancer Screening With the Multitarget Stool DNA Test. American Journal of Gastroenterology 2020; 115(11) doi: 10.14309/ajg.0000000000000968
|
| 36 |
Martha E. Shepherd, Ashlee Lecorps, Jon Harris-Shapiro, Lesley-Ann Miller-Wilson. Evaluating Outreach Methods for Multi-Target Stool DNA Test for Colorectal Cancer Screening Among an Employer Population. Journal of Primary Care & Community Health 2021; 12 doi: 10.1177/21501327211037892
|
| 37 |
Nicholas J Lazar, Ali Khreisat, Roa'a AlKloub, Alsadiq Al-Hillan, Michael Duffy. Inappropriate Multi-Target Stool DNA Use for Colorectal Cancer Screening: Risks, Compliance, and Outcomes. Cureus 2023; doi: 10.7759/cureus.40506
|
| 38 |
Joseph C. Anderson, Christina M. Robinson, William M. Hisey, David K. Edwards, Bonny L. Kneedler, Barry M. Berger, Lynn F. Butterly. Colorectal Neoplasia Detection in Individuals With Positive Multitarget Stool DNA Tests. Journal of Clinical Gastroenterology 2022; 56(5) doi: 10.1097/MCG.0000000000001554
|
| 39 |
Jason D. Eckmann, Derek W. Ebner, Jamie Bering, Allon Kahn, Eduardo Rodriguez, Mary E. Devens, Kari L. Lowrie, Karen Doering, Sara Then, Kelli N. Burger, Douglas W. Mahoney, David O. Prichard, Michael B. Wallace, Suryakanth R. Gurudu, Lila J. Finney, Paul Limburg, Barry Berger, David A. Ahlquist, John B. Kisiel. Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy. American Journal of Gastroenterology 2020; 115(4) doi: 10.14309/ajg.0000000000000546
|
| 40 |
Diana G. Redwood, Tuan A. Dinh, John B. Kisiel, Bijan J. Borah, James P. Moriarty, Ellen M. Provost, Frank D. Sacco, James J. Tiesinga, David A. Ahlquist. Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People. Mayo Clinic Proceedings 2021; 96(5) doi: 10.1016/j.mayocp.2020.07.035
|
| 41 |
Ahmed M. Ibrahim, Abdulmalik Saleem, Muhammad Salman Faisal, Kevin Harris, Raef A. Fadel, Mostafa A. Ibrahim, Suraj Suresh. Factors Associated with Advanced Adenoma Detection by Colonoscopy After Negative Multitarget Stool DNA Testing. Digestive Diseases and Sciences 2026; 71(6) doi: 10.1007/s10620-025-09595-7
|
| 42 |
碗宜 张. Advances in Screening Methods for Colorectal Cancer. Advances in Clinical Medicine 2023; 13(03) doi: 10.12677/ACM.2023.133424
|
| 43 |
Novel Approaches to Colorectal Cancer. Advances in Cancer Research 2021; 151 doi: 10.1016/bs.acr.2021.02.006
|
| 44 |
Sherri N. Sheinfeld Gorin, Masahito Jimbo, Robert Heizelman, Kathryn M. Harmes, Diane M. Harper. The future of cancer screening after COVID‐19 may be at home. Cancer 2021; 127(4) doi: 10.1002/cncr.33274
|
| 45 |
Christie A. Flanagan, Lila J. Finney Rutten, John B. Kisiel, Jennifer K. Lent, Joseph F. Bachtold, Andrew W. Swartz, Diana G. Redwood. Development of a colorectal cancer screening intervention for Alaska Native people during a pandemic year. Contemporary Clinical Trials Communications 2022; 30 doi: 10.1016/j.conctc.2022.101016
|
| 46 |
A. Mark Fendrick, Deborah A. Fisher, Leila Saoud, A. Burak Ozbay, Jordan J. Karlitz, Paul J. Limburg. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes. Cancer Prevention Research 2021; 14(9) doi: 10.1158/1940-6207.CAPR-21-0075
|
| 47 |
Manuel Zorzi, Emanuele Damiano Luca Urso. Impact of colorectal cancer screening on incidence, mortality and surgery rates: Evidences from programs based on the fecal immunochemical test in Italy. Digestive and Liver Disease 2023; 55(3) doi: 10.1016/j.dld.2022.08.013
|
| 48 |
Peter J. Mazzone, Peter B. Bach, Jacob Carey, Caitlin A. Schonewolf, Katalin Bognar, Manmeet S. Ahluwalia, Marcia Cruz-Correa, David Gierada, Sonali Kotagiri, Kathryn Lloyd, Fabien Maldonado, Jesse D. Ortendahl, Lecia V. Sequist, Gerard A. Silvestri, Nichole Tanner, Jeffrey C. Thompson, Anil Vachani, Kwok-Kin Wong, Ali H. Zaidi, Joseph Catallini, Ariel Gershman, Keith Lumbard, Laurel K. Millberg, Jeff Nawrocki, Carter Portwood, Aakanksha Rangnekar, Carolina Campos Sheridan, Niti Trivedi, Tony Wu, Yuhua Zong, Lindsey Cotton, Allison Ryan, Christopher Cisar, Alessandro Leal, Nicholas Dracopoli, Robert B. Scharpf, Victor E. Velculescu, Luke R. G. Pike. Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection. Cancer Discovery 2024; 14(11) doi: 10.1158/2159-8290.CD-24-0519
|
| 49 |
Derek W. Ebner, Kelli N. Burger, Brendan Broderick, Douglas W. Mahoney, Todd A. Kellogg, Andres Acosta, John B. Kisiel. Positive Predictive Value for Multitarget Stool DNA After Bariatric and Metabolic Surgery. Gastro Hep Advances 2023; 2(7) doi: 10.1016/j.gastha.2023.06.005
|